Skip to main content

Circumvent PCV-M G2 (Canada)

This page contains information on Circumvent PCV-M G2 for veterinary use.
The information provided typically includes the following:
  • Circumvent PCV-M G2 Indications
  • Warnings and cautions for Circumvent PCV-M G2
  • Direction and dosage information for Circumvent PCV-M G2

Circumvent PCV-M G2

This treatment applies to the following species:
Company: Merck Animal Health

Porcine Circovirus Vaccine, Type 2, Killed Baculovirus Vector

Mycoplasma Hyopneumoniae Bacterin

This product has been shown effective for the vaccination of healthy swine 3 days or 3 weeks of age or older against Porcine Circovirus Type 2 and Mycoplasma hyopneumoniae. Duration of immunity has been shown to be at least 20 weeks for Porcine Circovirus Type 2. Duration of immunity for Mycoplasma hyopneumoniae has not been established. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

This product has been shown effective against viremia and in the reduction of viral shedding and lymphoid infection caused by Porcine Circovirus Type 2 and lung lesions caused by Mycoplasma hyopneumoniae.

Composition: This product contains a subunit vaccine based on Porcine Circovirus Type 2a.

ADMINISTRATION and DOSAGE OPTIONS: Allow the vaccine to reach an ambient temperature of 16°-27°C (60°-80°F) and shake well prior to use. Use aseptic technique. OPTION 1: Vaccinate pigs intramuscularly at 3 weeks of age or older with a single 2 mL dose. OPTION 2: Vaccinate pigs intramuscularly as early as 3 days of age with a 1 mL dose followed by a second 1 mL dose 3 weeks later.

CAUTIONS: Store refrigerated at 2°-8°C (35°-46°F). Do not freeze. Shake well before using. Do not mix with other products. This product has not been tested in pregnant animals. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. The vaccine may induce significant localized adverse reactions, particularly following booster vaccination. Localized reactions resolve 1-35 days following vaccination. If allergic reaction occurs, treat with epinephrine. In the event of high maternal antibodies, vaccination at 3 days of age is not recommended. Caution should be used to avoid injecting your own fingers, hands, or other body parts. Accidental injection can cause serious local reactions. In case of human exposure, contact a physician.

PRESERVATIVES: Gentamicin and thimerosal.

FOR ANIMAL USE ONLY

Intervet Inc. d/b/a Merck Animal Health, Omaha, Nebraska 68103 USA

VLN 165A / PCN 49K5.R6

1 866 683-7838 (Canada)

 

 

Code

 

100 mL

Option 1: 50 Doses-2 mL

Option 2: 100 Doses-1 mL

131428

391624 R1

500 mL

Option 1: 250 Doses-2 mL

Option 2: 500 Doses-1 mL

143624

324621 R1

CPN: 1208265.1

MERCK ANIMAL HEALTH
Intervet Canada Corp.

16750 ROUTE TRANSCANADIENNE, KIRKLAND, QC, H9H 4M7
Order Desk:   514-428-7013
Toll-Free:   866-683-7838
Fax:   Toll-free 888-498-4444; local 514-428-7014
Website:   www.merck-animal-health.ca
THIS SERVICE AND DATA ARE PROVIDED "AS IS". Animalytix assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the Animalytix service and data. See the Terms of Use for further details.

Copyright © 2024 Animalytix LLC. Updated: 2024-02-27